Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   540,054    

Indirect Shares

   247,533      
Direct Value   $43,092,104    

Indirect Value

   $21,938,850      
Total Shares   787,587      
Total Value   $65,030,954      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $914,552 Immunome Inc. $149,513 Keros Therapeutics, Inc. $0 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $914,552 Immunome Inc. $149,513 Keros Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
            Keros Therapeutics, Inc. KROS 2024-06-01 200 0    Premium*  
* Premium Members only  

Records found :    853         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 16 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-27 4 AS $48.34 $193,360 D/D (4,000) 167,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-31 4 AS $48.62 $243,116 D/D (5,000) 167,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-01-04 4 AS $52.24 $156,731 D/D (3,000) 167,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-01-18 4 AS $54.00 $270,000 D/D (5,000) 167,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-11 4 S $38.01 $969,656 D/D (25,500) 168,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-14 4 S $38.13 $571,893 D/D (15,000) 168,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-16 4 AS $38.47 $577,370 D/D (15,000) 168,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-08 4 A $0.00 $0 D/D 56,000 169,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-11-07 4 S $47.00 $236,470 D/D (5,000) 169,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-21 4 AS $87.56 $6,106,478 D/D (69,744) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-22 4 AS $85.69 $5,976,515 D/D (69,743) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-12-29 4 AS $83.84 $335,360 D/D (4,000) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-12-30 4 AS $83.35 $333,400 D/D (4,000) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-06 4 AS $87.19 $348,760 D/D (4,000) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-09 4 AS $89.79 $359,160 D/D (4,000) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-10 4 AS $91.31 $365,240 D/D (4,000) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-11 4 AS $89.84 $359,360 D/D (4,000) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-25 4 AS $84.44 $422,200 D/D (5,000) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-01-26 4 AS $84.00 $420,000 D/D (5,000) 170,682 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-07 4 OE $9.86 $29,580 D/D 3,000 170,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-10 4 OE $12.99 $38,970 D/D 3,000 170,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-01-04 4 OE $12.99 $38,970 D/D 3,000 170,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-11-14 4 OE $12.99 $51,960 D/D 4,000 171,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-26 4 AS $48.38 $338,633 D/D (7,000) 171,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-04 4 OE $12.99 $64,950 D/D 5,000 172,691 0 -
  853  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16  17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35      
  Page 16 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us